2,166 results on '"Chen, Pei–Jer"'
Search Results
152. No Increase in Prevalence of Hepatitis B Surface Antigen Mutant in a Population of Children and Adolescents Who Were Fully Covered by Universal Infant Immunization
153. Hepatitis B Virus Basal Core Promoter Mutation and DNA Load Correlate with Expression of Hepatitis B Core Antigen in Patients with Chronic Hepatitis B
154. Sorafenib Action in Hepatitis B Virus X–Activated Oncogenic Androgen Pathway in Liver Through SHP-1
155. Pegylated Interferon-α-2a Plus Ribavirin for Treatment-Naive Asian Patients with Hepatitis C Virus Genotype 1 Infection: A Multicenter, Randomized Controlled Trial
156. Humoral and Cellular Immune Responses to a Hepatitis B Vaccine Booster 15-18 Years after Neonatal Immunization
157. DNA detection using commercial mobile phones
158. Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
159. Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
160. Hepatitis B Virus X Protein Enhances Androgen Receptor-Responsive Gene Expression Depending on Androgen Level
161. Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase
162. Sofosbuvir/velpatasvir or glecaprevir/pibrentasvir for treating patients with hepatitis C virus reinfection following direct‐acting antiviral‐induced sustained virologic response
163. Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA‐binding function
164. Safety and dose-escalation study of a targeted oncolytic adenovirus, suratadenoturev (OBP-301), in patients with refractory advanced liver cancer: Phase I clinical trial.
165. Dengue Virus Ribonucleic Acid Detection Rates in Blood Donors Correlate With Local Infection Incidences During a Dengue Outbreak in Taiwan
166. Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants
167. Exposure to Air Pollution and Survival in Follow-Up after Hepatocellular Carcinoma
168. An Immunocompetent Mouse Model for the Tolerance of Human Chronic Hepatitis B Virus Infection
169. Role of Hepatitis B Virus Precore/Core Promoter Mutations and Serum Viral Load on Noncirrhotic Hepatocellular Carcinoma: A Case-Control Study
170. Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan: Follow-up at 108 Weeks Posttreatment
171. Lack of Association between Infection with a Novel Human Coronavirus (HCoV), HCoV-NH, and Kawasaki Disease in Taiwan
172. Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy
173. Prolonged suppression of HBV in mice by a novel antibody that targets a unique epitope on hepatitis B surface antigen
174. Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations
175. Hepatitis C Viral Infection Increases the Risk of Lymphoid-Neoplasms: A Population-Based Cohort Study
176. Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA‐binding function.
177. # 2143 Distinct viral evolution and quasispecies dynamics between hepatitis B e antigen seroconverters and non-seroconverters in response to interferon-based therapy
178. # 1728 The NIACE score helps predict the survival of Asian hepatocellular carcinoma patients
179. Prevalence and Implication of a Newly Identified Infectious Agent (SEN Virus) in Taiwan
180. Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan
181. Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
182. Signatures of adaptive evolution during human to mink SARS CoV2 cross-species transmission inform estimates of the COVID19 pandemic timing
183. Sofosbuvir/velpatasvir or glecaprevir/pibrentasvir for treating patients with hepatitis C virus reinfection following direct‐acting antiviral‐induced sustained virologic response
184. A miniaturized quantitative polymerase chain reaction system for DNA amplification and detection
185. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
186. Gender disparity in chronic hepatitis B: Mechanisms of sex hormones
187. Development of Risk Scoring System for Stratifying Population for Hepatocellular Carcinoma Screening
188. Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma
189. Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial
190. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
191. Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages
192. Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
193. Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway
194. Structure and Replication of the Genome of the Hepatitis δ Virus
195. Continuous Expression and Replication of the Hepatitis δ Virus Genome in Hep G2 Hepatoblastoma Cells Transfected with Cloned Viral DNA
196. The Large Form of Hepatitis δ Antigen is Crucial for Assembly of Hepatitis δ Virus
197. Transient Immunoglobulin M Antibody Response to Hepatitis C Virus Capsid Antigen in Posttransfusion Hepatitis C: Putative Serological Marker for Acute Viral Infection
198. Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management
199. Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
200. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.